Advanced Enzyme [ADVENZYMES] vs Rossari Biotech [ROSSARI] Detailed Stock Comparison

Advanced Enzyme
NSE
Loading...

Rossari Biotech
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Advanced Enzyme wins in 10 metrics, Rossari Biotech wins in 10 metrics, with 0 ties. Both stocks appear equally matched on key metrics.
View Metrics Details
Vital Metrics Comparison
Metric | Advanced Enzyme | Rossari Biotech | Better |
---|---|---|---|
P/E Ratio (TTM) | 25.13 | 25.71 | Advanced Enzyme |
Price-to-Book Ratio | 2.42 | 2.93 | Advanced Enzyme |
Debt-to-Equity Ratio | 2.68 | 18.39 | Advanced Enzyme |
PEG Ratio | 1.47 | -6.50 | Rossari Biotech |
EV/EBITDA | 15.56 | 14.31 | Rossari Biotech |
Profit Margin (TTM) | 20.48% | 6.33% | Advanced Enzyme |
Operating Margin (TTM) | 25.18% | 9.22% | Advanced Enzyme |
EBITDA Margin (TTM) | 25.18% | 9.22% | Advanced Enzyme |
Return on Equity | 8.93% | 11.50% | Rossari Biotech |
Return on Assets (TTM) | 8.09% | 7.19% | Advanced Enzyme |
Free Cash Flow (TTM) | $1.08B | $-210.69M | Advanced Enzyme |
Dividend Yield | 1.56% | 6.54% | Rossari Biotech |
1-Year Return | -28.36% | -31.14% | Advanced Enzyme |
Price-to-Sales Ratio (TTM) | 5.14 | 1.63 | Rossari Biotech |
Enterprise Value | $29.31B | $35.72B | Rossari Biotech |
EV/Revenue Ratio | 4.39 | 1.67 | Rossari Biotech |
Gross Profit Margin (TTM) | 73.08% | 31.70% | Advanced Enzyme |
Revenue per Share (TTM) | $60 | $386 | Rossari Biotech |
Earnings per Share (Diluted) | $12.22 | $24.39 | Rossari Biotech |
Beta (Stock Volatility) | 0.37 | 0.27 | Rossari Biotech |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Advanced Enzyme vs Rossari Biotech Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
Stock | 1D | 1W | 1M | 3M | 6M | YTD |
---|---|---|---|---|---|---|
Advanced Enzyme | 0.65% | -1.60% | -4.70% | 7.21% | -0.50% | -12.42% |
Rossari Biotech | 1.92% | -4.61% | -10.19% | -10.47% | -1.65% | -20.97% |
Long-term Returns
Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
---|---|---|---|---|---|---|
Advanced Enzyme | -28.36% | 15.08% | 30.43% | 7.83% | 7.83% | 7.83% |
Rossari Biotech | -31.14% | -32.97% | -21.21% | -14.24% | -14.24% | -14.24% |
Performance & Financial Health Analysis: Advanced Enzyme vs Rossari Biotech
Metric | ADVENZYMES | ROSSARI |
---|---|---|
Market Information | ||
Market Cap | ₹34.36B | ₹34.72B |
Market Cap Category | Small cap | Small cap |
10 Day Avg. Volume | 666,128 | 54,728 |
90 Day Avg. Volume | 479,369 | 118,973 |
Last Close | ₹309.10 | ₹639.10 |
52 Week Range | ₹257.90 - ₹571.00 | ₹569.00 - ₹972.70 |
% from 52W High | -45.87% | -34.30% |
All-Time High | ₹571.00 (Sep 16, 2024) | ₹1,619.00 (Oct 11, 2021) |
% from All-Time High | -45.87% | -60.53% |
Growth Metrics | ||
Quarterly Revenue Growth | 0.20% | 0.11% |
Quarterly Earnings Growth | 0.17% | -0.04% |
Financial Health | ||
Profit Margin (TTM) | 0.20% | 0.06% |
Operating Margin (TTM) | 0.25% | 0.09% |
Return on Equity (TTM) | 0.09% | 0.12% |
Debt to Equity (MRQ) | 2.68 | 18.39 |
Cash & Liquidity | ||
Book Value per Share (MRQ) | ₹127.00 | ₹214.12 |
Cash per Share (MRQ) | ₹52.94 | ₹21.20 |
Operating Cash Flow (TTM) | ₹1.70B | ₹440.09M |
Levered Free Cash Flow (TTM) | ₹1.31B | ₹1.36B |
Dividends | ||
Last 12-Month Dividend Yield | 1.56% | 6.54% |
Last 12-Month Dividend | ₹5.20 | ₹43.78 |
Valuation & Enterprise Metrics Analysis: Advanced Enzyme vs Rossari Biotech
Metric | ADVENZYMES | ROSSARI |
---|---|---|
Price Ratios | ||
P/E Ratio (TTM) | 25.13 | 25.71 |
Forward P/E | 24.67 | 18.70 |
PEG Ratio | 1.47 | -6.50 |
Price to Sales (TTM) | 5.14 | 1.63 |
Price to Book (MRQ) | 2.42 | 2.93 |
Market Capitalization | ||
Market Capitalization | ₹34.36B | ₹34.72B |
Enterprise Value | ₹29.31B | ₹35.72B |
Enterprise Value Metrics | ||
Enterprise to Revenue | 4.39 | 1.67 |
Enterprise to EBITDA | 15.56 | 14.31 |
Risk & Other Metrics | ||
Beta | 0.37 | 0.27 |
Book Value per Share (MRQ) | ₹127.00 | ₹214.12 |
Financial Statements Comparison: Advanced Enzyme vs Rossari Biotech
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
Metric (MRQ) | ADVENZYMES | ROSSARI |
---|---|---|
Revenue/Sales | ₹1.86B | ₹5.44B |
Cost of Goods Sold | ₹500.49M | ₹3.71B |
Gross Profit | ₹1.36B | ₹1.72B |
Research & Development | N/A | N/A |
Operating Income (EBIT) | ₹468.14M | ₹501.06M |
EBITDA | ₹652.82M | ₹695.76M |
Pre-Tax Income | ₹549.00M | ₹460.99M |
Income Tax | ₹144.60M | ₹125.03M |
Net Income (Profit) | ₹404.40M | ₹335.96M |
Balance Sheet & Liquidity Metrics (MRQ)
Metric (MRQ) | ADVENZYMES | ROSSARI |
---|---|---|
Cash & Equivalents | ₹942.25M | ₹442.02M |
Total Current Assets | ₹8.80B | ₹10.42B |
Total Current Liabilities | ₹967.55M | ₹5.37B |
Long-Term Debt | ₹209.17M | ₹1.22B |
Total Shareholders Equity | ₹14.69B | ₹11.85B |
Retained Earnings | ₹11.53B | ₹6.97B |
Property, Plant & Equipment | ₹2.93B | ₹0 |
Cash Flow Statement Comparison (MRQ)
Metric (MRQ) | ADVENZYMES | ROSSARI |
---|---|---|
Operating Cash Flow | N/A | N/A |
Capital Expenditures | N/A | N/A |
Free Cash Flow | N/A | N/A |
Debt Repayment | N/A | N/A |
Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
Metric | ADVENZYMES | ROSSARI |
---|---|---|
Shares Short | N/A | N/A |
Short Ratio | N/A | N/A |
Short % of Float | N/A | N/A |
Average Daily Volume (10 Day) | 666,128 | 54,728 |
Average Daily Volume (90 Day) | 479,369 | 118,973 |
Shares Outstanding | 111.88M | 55.36M |
Float Shares | 29.32M | 16.51M |
% Held by Insiders | 0.56% | 0.68% |
% Held by Institutions | 0.21% | 0.21% |
Dividend Analysis & Yield Comparison: Advanced Enzyme vs Rossari Biotech
Metric | ADVENZYMES | ROSSARI |
---|---|---|
Last 12-Month Dividend | ₹5.20 | ₹43.78 |
Last 12-Month Dividend Yield | 1.56% | 6.54% |
3-Year Avg Annual Dividend | ₹5.43 | ₹14.93 |
3-Year Avg Dividend Yield | 0.75% | 1.66% |
3-Year Total Dividends | ₹16.30 | ₹44.78 |
Ex-Dividend Date | Jul 23, 2025 | Jun 20, 2025 |